NK-cell lymphomas and leukemias - A spectrum of tumors with variable manifestations and immunophenotype

被引:86
|
作者
Hasserjian, Robert P.
Harris, Nancy Lee
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
natural killer cell; T cell; lymphoma; leukemia;
D O I
10.1309/2F39NX1AL3L54WU8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Natural killer (NK) cells are lymphocytes that have some phenotypic and functional similarities to cytotoxic T cells but do not express the T-cell receptor complex. NK-cell malignancies may be localized or disseminated at initial examination, and most behave aggressively. The variable presentation of NK-cell lymphomas and leukemias suggests that they represent a spectrum Of disease, with Epstein-Barr virus (EBV) implicated in the pathogenesis of most cases. Using cases presented in Session 10 of the 2005 Society for Hematopathology/European Association for Haematopathology Workshop on T-cell and NK-cell malignancies, we discuss outstanding issues in the classification and diagnosis of NK-cell malignancies. These difficulties are related to unusual sites of manifestation, atypical immunophenotypic features, and EBV+ T-cell tumors that resemble classical extranodal NK/T-cell lymphoma, nasal-type (EN-NK/T-NT). Although some of these cases can be grouped into EN-NK/T-NT, classification of tumors that have atypical or discordant features will remain controversial, particularly when EBV is absent.
引用
收藏
页码:860 / 868
页数:9
相关论文
共 50 条
  • [41] Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies
    N K El-Mallawany
    J K Frazer
    P Van Vlierberghe
    A A Ferrando
    S Perkins
    M Lim
    Y Chu
    M S Cairo
    Blood Cancer Journal, 2012, 2 : e65 - e65
  • [42] Primary and secondary central nervous system mature T- and NK-cell lymphomas
    Pang, Yifan
    Chihara, Dai
    SEMINARS IN HEMATOLOGY, 2021, 58 (02) : 123 - 129
  • [43] Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas
    Bhansali, Rahul S.
    Barta, Stefan K.
    CANCERS, 2023, 15 (03)
  • [44] Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies
    El-Mallawany, N. K.
    Frazer, J. K.
    Van Vlierberghe, P.
    Ferrando, A. A.
    Perkins, S.
    Lim, M.
    Chu, Y.
    Cairo, M. S.
    BLOOD CANCER JOURNAL, 2012, 2 : e65 - e65
  • [45] STAT1 expression is associated with EBV status in T/NK-cell lymphomas
    Escriva, Patricia
    Lejeune, Marylene
    Bosch, Ramon
    Lopez, Carlos
    Gonzalez, Miriam
    Salvado, M. Teresa
    Jaen, Joaquin
    Pons, Lluis E.
    Alvaro, Tomas
    VIRCHOWS ARCHIV, 2008, 452 : S3 - S3
  • [46] Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
    Ng, Samuel Y.
    Yoshida, Noriaki
    Christie, Amanda L.
    Ghandi, Mahmoud
    Dharia, Neekesh V.
    Dempster, Joshua
    Murakami, Mark
    Shigemori, Kay
    Morrow, Sara N.
    Van Scoyk, Alexandria
    Cordero, Nicolas A.
    Stevenson, Kristen E.
    Puligandla, Maneka
    Haas, Brian
    Lo, Christopher
    Meyers, Robin
    Gao, Galen
    Cherniack, Andrew
    Louissaint, Abner, Jr.
    Nardi, Valentina
    Thorner, Aaron R.
    Long, Henry
    Qiu, Xintao
    Morgan, Elizabeth A.
    Dorfman, David M.
    Fiore, Danilo
    Jang, Julie
    Epstein, Alan L.
    Dogan, Ahmet
    Zhang, Yanming
    Horwitz, Steven M.
    Jacobsen, Eric D.
    Santiago, Solimar
    Ren, Jian-Guo
    Guerlavais, Vincent
    Annis, D. Allen
    Aivado, Manuel
    Saleh, Mansoor N.
    Mehta, Amitkumar
    Tsherniak, Aviad
    Root, David
    Vazquez, Francisca
    Hahn, William C.
    Inghirami, Giorgio
    Aster, Jon C.
    Weinstock, David M.
    Koch, Raphael
    NATURE COMMUNICATIONS, 2018, 9
  • [47] Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
    Samuel Y. Ng
    Noriaki Yoshida
    Amanda L. Christie
    Mahmoud Ghandi
    Neekesh V. Dharia
    Joshua Dempster
    Mark Murakami
    Kay Shigemori
    Sara N. Morrow
    Alexandria Van Scoyk
    Nicolas A. Cordero
    Kristen E. Stevenson
    Maneka Puligandla
    Brian Haas
    Christopher Lo
    Robin Meyers
    Galen Gao
    Andrew Cherniack
    Abner Louissaint
    Valentina Nardi
    Aaron R. Thorner
    Henry Long
    Xintao Qiu
    Elizabeth A. Morgan
    David M. Dorfman
    Danilo Fiore
    Julie Jang
    Alan L. Epstein
    Ahmet Dogan
    Yanming Zhang
    Steven M. Horwitz
    Eric D. Jacobsen
    Solimar Santiago
    Jian-Guo Ren
    Vincent Guerlavais
    D. Allen Annis
    Manuel Aivado
    Mansoor N. Saleh
    Amitkumar Mehta
    Aviad Tsherniak
    David Root
    Francisca Vazquez
    William C. Hahn
    Giorgio Inghirami
    Jon C. Aster
    David M. Weinstock
    Raphael Koch
    Nature Communications, 9
  • [48] A phse I/II trial of clofarabine in patients with relapsed T-cell or NK-cell lymphomas
    Mulford, D. A.
    Pohiman, B. L.
    Hamlin, P. A.
    Young, F.
    Pamer, E.
    Horwitz, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Manifestation and prognostic value of EBV serology in nasal/nasopharyngeal T and NK-cell lymphomas.
    Zhang, Y.
    Huang, Y.
    Xiao, J.
    Xia, Y.
    Lu, T.
    Lin, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 445S - 445S
  • [50] PD-L1 Expression in T and NK-cell Lymphomas: A New Therapeutic Target
    Anderson, Joshua
    Wang, Linlin
    LABORATORY INVESTIGATION, 2017, 97 : 336A - 336A